This inventor holds 1 USPTO granted patent and 1 published patent application and 4 EPO patents. Top assignee: Innovata Biomed Limited. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: John Philip Briant: Innovator in Dry Powder Inhaler Technology
Introduction
John Philip Briant is a notable inventor based in Royston, GB. He is recognized for his contributions to the field of inhalation technology, particularly through his innovative designs that enhance the delivery of medication.
Latest Patents
John Philip Briant holds a patent for a dry powder inhaler. This device comprises at least one medicament reservoir and a closure member engaged with the reservoir to close an opening therein. A surface of the reservoir adjacent to the opening and a surface of the closure member are in abutment, either directly or via a seal member interposed between the reservoir and the closure member. At least one abutting surface is formed with a projection that increases the contact pressure between said surfaces, thereby improving the seal between them and reducing the potential for ingress of moisture into the reservoir.
Career Highlights
Throughout his career, Briant has worked with prominent companies in the pharmaceutical industry, including Innovata Biomed Limited and AstraZeneca. His work has significantly impacted the development of inhalation devices, making them more effective for patients.
Collaborations
John Philip Briant has collaborated with notable professionals in his field, including James Gordon and Andrew Paul Morris. These collaborations have contributed to the advancement of inhalation technology and the improvement of patient care.
Conclusion
John Philip Briant's innovative work in the development of dry powder inhalers showcases his commitment to enhancing medical technology. His contributions continue to influence the pharmaceutical industry and improve the lives of patients who rely on inhalation therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile